Clinical Trials Directory

Trials / Conditions / Frontotemporal Dementia

Frontotemporal Dementia

105 registered clinical trials studyying Frontotemporal Dementia26 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationResearch Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM D
NCT07222605
eQ8Health Corporation d/b/a CareONE ConciergeN/A
RecruitingSTELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
NCT06613204
Oregon Health and Science UniversityN/A
RecruitingVortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
NCT06604520
Johns Hopkins UniversityPhase 2
Active Not RecruitingMusic, Social Attention, and Dementia
NCT06768996
University of California, San FranciscoN/A
CompletedStudy in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmaco
NCT06705192
Mads KjolbyPhase 1
RecruitingUsing the EHR to Advance Genomic Medicine Across a Diverse Health System
NCT06377033
University of PennsylvaniaN/A
UnknownThe Clinical Impact of the Novel Alzheimer's Blood-based Biomarkers
NCT06246019
Hospital del Mar Research Institute (IMIM)
WithdrawnDigital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS
NCT05830214
University of Alberta
RecruitingProteinopathies Expression in Skin of Neurodegenerative Disorders
NCT06528964
Universidad Autonoma de San Luis Potosí
RecruitingLemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
NCT06093126
Nova Scotia Health AuthorityPhase 4
RecruitingImproving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and
NCT06529744
University Health Network, Toronto
RecruitingA Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-t
NCT06064890
AviadoBio LtdPhase 1 / Phase 2
Active Not RecruitingA Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
NCT05956834
Massachusetts General Hospital
CompletedEfficacy Study of Kinto Care Coaching for Dementia Family Caregivers
NCT05916664
KintoN/A
RecruitingGenetic Frontotemporal Dementia Initiative for Neurodevelopment
NCT05779813
Western University
RecruitingNabilone for Agitation in Frontotemporal Dementia
NCT05742698
Simon Ducharme, MDPhase 2
Active Not RecruitingA Study of Caregiver Connections Via Technology in Dementia
NCT05779839
Mayo ClinicN/A
UnknownStories in the Moment: Dance Program for People Living With Dementia
NCT06221202
DanceStream ProjectsN/A
CompletedAutobiographical Specificity
NCT05642351
Nantes University Hospital
CompletedLong-term Effect of TMS in Primary Progressive Aphasia
NCT05842473
Hospital San Carlos, MadridN/A
CompletedThe Care Ecosystem Consortium Effectiveness Study
NCT05669365
University of California, San FranciscoN/A
UnknownSubgenual Cingulate Deep Brain STIMulation for Apathetic Behavioral Variant FRONtotemporal Dementia
NCT05699330
University Health Network, TorontoN/A
CompletedGroup-Based Telehealth Music Therapy Intervention for Patients With Dementia: A Pilot Study
NCT05508646
Geisinger ClinicN/A
RecruitingNon-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
NCT05326750
Kuopio University HospitalN/A
RecruitingNYSCF Scientific Discovery Biobank
NCT06203106
New York Stem Cell Foundation Research Institute
RecruitingTanycytes in Alzheimer's Disease and Frontotemporal Dementia
NCT05288842
University Hospital, Lille
WithdrawnA Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Deme
NCT05497817
Mayo ClinicN/A
CompletedA Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research
NCT05444244
University of Wisconsin, MadisonN/A
Active Not RecruitingThe Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia
NCT05315661
Samsung Medical CenterPhase 1
CompletedBetter Living With Non-memory-led Dementia
NCT05525377
University College, LondonN/A
CompletedNeurological Soft Signs in Neurodegenerative Dementias
NCT06354933
University of Milano Bicocca
Active Not RecruitingA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Part
NCT05262023
Denali Therapeutics Inc.Phase 1 / Phase 2
Active Not RecruitingSociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register S
NCT06209515
Kuopio University Hospital
CompletedWeCareAdvisor Study for Caregivers of People Living With Dementia
NCT05012410
Drexel UniversityN/A
RecruitingFirst-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
NCT05374278
David WilsonPhase 1 / Phase 2
CompletedA Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD
NCT04993755
Transposon Therapeutics, Inc.Phase 2
RecruitingA Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes
NCT04747431
Passage Bio, Inc.Phase 1 / Phase 2
CompletedEpidemiological Study in FRONtoTemporal Dementia
NCT05075187
CENTOGENE GmbH Rostock
UnknownEffects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality o
NCT05004558
Drexel UniversityN/A
CompletedMindfulness-Based Stress Reduction in Dementia Caregivers
NCT04977245
University of California, San FranciscoN/A
CompletedCare of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (P
NCT04165213
University of PennsylvaniaN/A
Enrolling By InvitationExplore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450
Peking University Third Hospital
CompletedClinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorder
NCT04939818
Novoic Limited
CompletedDopaminergic Therapy for Frontotemporal Dementia Patients
NCT04937452
I.R.C.C.S. Fondazione Santa LuciaPhase 2
CompletedSupport Via Technology: Living and Learning With Advancing FTD
NCT05338710
Oregon Health and Science UniversityN/A
Active Not RecruitingPhenotype, Genotype and Biomarkers 2
NCT04875416
University of Miami
UnknownGamma-Induction in FrontoTemporal Dementia Trial
NCT04425148
Massachusetts General HospitalN/A
UnknownTau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases
NCT05260151
Xuanwu Hospital, Beijing
Active Not RecruitingPhase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD
NCT04408625
Prevail TherapeuticsPhase 1 / Phase 2
Active Not RecruitingNeurofilament Surveillance Project (NSP)
NCT04516499
The Bluefield Project to Cure Frontotemporal Dementia
TerminatedA Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
NCT04374136
Alector Inc.Phase 3
CompletedFeasibility of Passive Data Collection in Dementia Subjects With Agitation
NCT04413851
HealthMode Inc.
Active Not RecruitingSafety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
NCT04220021
University of FloridaPhase 2
RecruitingLongitudinal Cognitive Assessment by BoCA
NCT04114994
Alzheimer's Light LLC
CompletedA Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRON
NCT03987295
Alector Inc.Phase 2
CompletedVoices Of Individuals: Challenges and Experiences Of bvFTD
NCT04060082
University of Pennsylvania
CompletedPalmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Tri
NCT04489017
I.R.C.C.S. Fondazione Santa LuciaPhase 2
RecruitingGENetic Fronto Temporal Dementia Initiative in Lille
NCT04639622
University Hospital, LilleN/A
CompletedThe Music, Sleep and Dementia Study
NCT04157244
University of PennsylvaniaN/A
CompletedIn-Home Technology for Dementia Caregivers
NCT03828383
University of California, BerkeleyN/A
Active Not RecruitingTRIAL READY (Clinical Trial Readiness)
NCT03912987
University of Miami
CompletedMultimodal Ocular Imaging in Neurodegeneration
NCT03699644
University of Michigan
CompletedConnectomics in Psychiatric Classification
NCT03967535
Washington University School of Medicine
CompletedA First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (G
NCT03636204
Alector Inc.Phase 1
CompletedEvaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Pr
NCT03510572
Asan Medical CenterEARLY_Phase 1
UnknownIntranasal Oxytocin for Frontotemporal Dementia
NCT03260920
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sPhase 2
CompletedCognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)
NCT03088956
Biogen
Completed18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls
NCT03625128
Chang Gung Memorial HospitalEARLY_Phase 1
CompletedRHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia
NCT03923517
Technical University of MunichN/A
RecruitingInvestigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal
NCT03225144
National Institute of Neurological Disorders and Stroke (NINDS)
RecruitingRetinal Imaging in Neurodegenerative Disease
NCT03233646
Duke University
CompletedFlortaucipir PET Imaging in Subjects With FTD
NCT03040713
Avid RadiopharmaceuticalsPhase 1
CompletedMore Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
NCT03076671
University of Colorado, DenverN/A
CompletedRehabilitative Trial for the Rescue of Neurophysiological Parameters in Progranulin Deficient Subjects
NCT02999282
Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaN/A
RecruitingMolecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias
NCT02945774
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sN/A
RecruitingNeurologic Stem Cell Treatment Study
NCT02795052
MD Stem CellsN/A
CompletedThe Healthy Patterns Sleep Study
NCT03682185
University of PennsylvaniaPhase 3
CompletedEfficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia
NCT02506036
Johns Hopkins UniversityN/A
CompletedQuantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrat
NCT02496312
Institut National de la Santé Et de la Recherche Médicale, FranceN/A
Enrolling By InvitationPhenotype, Genotype & Biomarkers in ALS and Related Disorders
NCT02327845
University of Miami
CompletedStudy of the Neural Basis of Analogical Reasoning
NCT02236832
Institut National de la Santé Et de la Recherche Médicale, FranceN/A
CompletedThe Ontario Neurodegenerative Disease Research Initiative
NCT04104373
Ontario Neurodegeneration Disease Research Initiative
CompletedYoung Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family
NCT02055092
Norwegian Centre for Ageing and Health
CompletedComputational Tools for Early Diagnosis of Memory Disorders
NCT02050464
University of Eastern Finland
CompletedImpact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia
NCT01937013
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sPhase 2
CompletedCommunication Bridge Speech Therapy Research Study
NCT02439853
University of ChicagoN/A
CompletedEvaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrom
NCT02819700
Centre Hospitalier Universitaire, Amiens
UnknownEEG and TMS-based Biomarkers of ALS, MS and FTD
NCT04918251
University of Dublin, Trinity College
CompletedOlfactory Deficits in Neurologic Disease
NCT05019014
Massachusetts General Hospital
CompletedSafety Study of Intranasal Oxytocin in Frontotemporal Dementia
NCT01386333
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sPhase 1
CompletedEvaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGN
NCT00938665
Neuronetrix, Inc.
RecruitingCerebro Spinal Fluid Collection (CSF)
NCT04844060
University Hospital, Strasbourg, France
UnknownStudy of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
NCT01147679
University of California, Los Angeles
CompletedOxytocin and Social Cognition in Frontotemporal Dementia
NCT01002300
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sN/A
CompletedImaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and N
NCT01890343
Avid RadiopharmaceuticalsPhase 2
WithdrawnA Composite MR Neuroimaging Marker for Alzheimer's Disease
NCT01615666
Medical College of Wisconsin
WithdrawnGenetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Diso
NCT01459302
University of Massachusetts, Worcester
CompletedCOMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
NCT02860338
Clionsky Neuro Systems Inc.
Enrolling By InvitationImaging of Brain Amyloid Plaques in the Aging Population
NCT00950430
Mayo ClinicPhase 4
RecruitingCharacterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementi
NCT01353430
University of California, Irvine
CompletedOpen Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
NCT00594737
Tiffany Chow, MDPhase 3
CompletedSerotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
NCT00376051
Sunnybrook Health Sciences CentrePhase 4
CompletedA Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Front
NCT00416169
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
TerminatedAmyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT00159198
Assistance Publique - Hôpitaux de Paris
No Longer AvailableAn Open-Label, Expanded Access Protocol of LAM-002A in C9ORF72-Associated Frontotemporal Dementia (FTD)
NCT05483322
OrphAI Therapeutics